- Home
- ECX vs FDMT Comparison
ECX vs FDMT Comparison
Compare ECX & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECX | FDMT |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United Kingdom | United States |
| Employees | 1918 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 560.1M | 515.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | ECX | FDMT |
|---|---|---|
| Price | $1.19 | $10.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $31.71 |
| AVG Volume (30 Days) | ★ 2.0M | 800.7K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $85,209,000.00 |
| Revenue This Year | $819.14 | N/A |
| Revenue Next Year | $32.36 | $70.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $0.84 | $2.96 |
| 52 Week High | $2.70 | $12.34 |
Technical Indicators
Market Signals| Indicator | ECX | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 55.60 |
| Support Level | $1.20 | $9.85 |
| Resistance Level | $2.17 | $10.69 |
| Average True Range (ATR) | 0.08 | 0.61 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 98.45 | 62.55 |
Price Performance
Historical ComparisonAbout ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).